Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2007
06/20/2007EP1797088A1 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
06/20/2007EP1797087A1 Carbo- and hetero-cyclic antibiotics and use thereof
06/20/2007EP1797086A1 Indole derivatives, their manufacture and use as pharmaceutical agents
06/20/2007EP1797085A1 Thiazolinone 4-monosubstituted quinolines
06/20/2007EP1797084A1 NOVEL HETEROCYCLIC NF-kB INHIBITORS
06/20/2007EP1797083A1 Sulfonamide compounds
06/20/2007EP1797082A1 Carbostyril compound
06/20/2007EP1797080A1 Novel substituted thiophencarboxylic acid amides, production thereof and use thereof as medicaments
06/20/2007EP1797079A1 Proline derivatives
06/20/2007EP1797078A1 Compounds, compositions containing them, preparation thereof and uses thereof iii
06/20/2007EP1797077A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i
06/20/2007EP1797076A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
06/20/2007EP1797075A1 Benzimidazole derivatives and their use as cannabinoid receptor ligands
06/20/2007EP1797074A1 Compounds, compositions containing them, preparation thereof and uses thereof iiii
06/20/2007EP1797073A2 Bicyclic anilide spirolactam cgrp receptor antagonists
06/20/2007EP1797071A1 Carbonyl compounds usable as coagulation factor xa inhibitors
06/20/2007EP1797070A1 Compounds, compositions containing them, preparations thereof and uses thereof ii
06/20/2007EP1797067A1 New heterocyclic amides
06/20/2007EP1797065A2 Acyclic 1,3-diamines and uses therefor
06/20/2007EP1797064A1 Novel compounds useful for modulating abnormal cell proliferation
06/20/2007EP1797062A1 Alkynyl based dervatives of benzophenone as non-nucleoside reverse transcriptase inhibitors
06/20/2007EP1797054A2 Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds
06/20/2007EP1797053A1 Wound healing
06/20/2007EP1797051A1 Benzoxazine and quinoxaline derivatives and uses
06/20/2007EP1797050A1 Hiv inhibiting 1.2.4-triazin-6-one derivates
06/20/2007EP1797048A2 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines
06/20/2007EP1797047A1 Hiv inhibiting 5-substituted pyrimidines
06/20/2007EP1797046A2 Novel processes for preparing amorphous rosuvastatin calcium and a novel polymorphic form of rosuvastatin sodium
06/20/2007EP1797045A1 Novel pyrimidine derivatives and their use as ppar-alpha modulators
06/20/2007EP1797044A2 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
06/20/2007EP1797043A1 4-(phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists
06/20/2007EP1797042A1 Indozolone derivatives as 11b-hsd1 inhibitors
06/20/2007EP1797040A1 Muscarinic receptor antagonists
06/20/2007EP1797038A1 Thermodynamically stable form of bay 43-9006 tosylate
06/20/2007EP1797036A1 Sigma receptor ligands
06/20/2007EP1797035A2 Cyclopropyl piperidine glycine transporter inhibitors
06/20/2007EP1797034A1 Sulfonyl compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
06/20/2007EP1797033A2 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof
06/20/2007EP1797032A1 Polymorphs of the cysteine protease inhibitor n-(1-cyanocyclopropyl)-3-cyclopropylmethanesulfonyl-2(r)-[2,2,2-trifluoro-1(s)-(4-fluorophenyl)ethylamino]propionamide
06/20/2007EP1797031A1 Medicinal disulfide salts
06/20/2007EP1796793A2 Novel compounds
06/20/2007EP1796752A1 Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions
06/20/2007EP1796734A1 Contrast agent formulations for the visualization of the lymphatic system
06/20/2007EP1796732A2 Modified small interfering rna molecules and methods of use
06/20/2007EP1796730A2 Stabilized leukotriene b4 (ltb4) agent pharmaceutical
06/20/2007EP1796729A1 Liposomes with improved drug retention for treatment of cancer
06/20/2007EP1796728A2 Method and composition for preventing or treating diarrhea
06/20/2007EP1796727A2 Method for the treatment of polycystic kidney disease
06/20/2007EP1796725A1 Treatment or prevention of unscheluded bleeding in women on progestogen containing medication
06/20/2007EP1796716A2 Chemokine combinations to mobilize progenitor/stem cells
06/20/2007EP1796691A1 Inorganic selenium for treatment of cancer
06/20/2007EP1796690A2 Cartilage filling device
06/20/2007EP1796689A1 Free or liposomal gemcitabine alone or in combination with free or liposomal idarubicin
06/20/2007EP1796688A1 Pancreatic cancer treatment using na+/k+ atpase inhibitors
06/20/2007EP1796687A2 Combination therapy for controlled carbohydrate digestion
06/20/2007EP1796686A2 Emmprin antagonists and uses thereof
06/20/2007EP1796685A1 Pyridoxal-5´-phosphate and related compounds in combination with therapeutic cadiovascular compounds for treating angina.
06/20/2007EP1796684A1 Vitamin b6 related compounds and methods for recovery from trauma
06/20/2007EP1796683A1 Methods and compositions for the administration of calcium chelators, bisphosphonates and/or citrate compounds and their pharmaceutical uses
06/20/2007EP1796682A2 Method and composition for treating patients undergoing kidney dialysis
06/20/2007EP1796681A2 Compounds for inhibiting copper-containing amine oxidases and uses thereof
06/20/2007EP1796680A2 Methods of treating symptoms of multiple sclerosis using vitamin d and related compounds
06/20/2007EP1796679A1 Ciclesonide and syk inhibitor combination and methods of use thereof
06/20/2007EP1796678A2 Carboxamide spirolactam cgrp receptor antagonists
06/20/2007EP1796677A2 Method for activating trpv4 channel receptors by agonists
06/20/2007EP1796676A2 Transdermal administration of phycotoxins
06/20/2007EP1796675A2 Compositions and methods for treating ophthalmic diseases
06/20/2007EP1796674A2 5-phenoxyalkoxypsoralens and methods for selective inhibition of the voltage gated kv1.3 potassium channel
06/20/2007EP1796673A2 Novel pyrimidine compounds, process for their preparation and compositions containing them
06/20/2007EP1796672A1 Cancer combination therapy comprising azd2171 and imatinib
06/20/2007EP1796671A1 Amorphous form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
06/20/2007EP1796670A1 Process to prepare camptothecin derivatives and novel intermediate and compounds thereof
06/20/2007EP1796669A2 Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
06/20/2007EP1796668A1 Aqueous pharmaceutical preparation comprising roflumilast
06/20/2007EP1796667A2 Muscarinic receptor antagonists
06/20/2007EP1796666A1 Methods and compositions for the treatment of hyperlipidemia
06/20/2007EP1796665A2 Compounds for the treatment of dyslipidemia and other lipid disorders
06/20/2007EP1796664A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
06/20/2007EP1796663A2 Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators
06/20/2007EP1796662A2 Inhibition of viruses using rnase h inhibitors
06/20/2007EP1796661A2 Large-scale manufacturing process for the production of pharmaceutical compositions
06/20/2007EP1796660A2 Use of tellurium compounds for inhibition of interleukin-converting enzyme
06/20/2007EP1796658A2 Dopaminergic mimetics
06/20/2007EP1796657A2 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
06/20/2007EP1796656A2 Composition for inhibiting or preventing the formation of a biofilm
06/20/2007EP1796655A2 Use of modulators of a novel form of muscle selective calcineurin interacting protein (mcip-1-38) as a treatment for cardiovascular diseases
06/20/2007EP1796654A1 Skin cooling compositions
06/20/2007EP1796653A2 Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
06/20/2007EP1796645A1 Agglomeration of sterol particles having a particular size
06/20/2007EP1796644A2 Drug delivery from embolic agents
06/20/2007EP1796643A1 Treatment of androgen - deprivation induced osteoporosis
06/20/2007EP1796641A1 A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
06/20/2007EP1796637A1 Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough and tussive attacks
06/20/2007EP1796635A2 D-methionine formulation with improved biopharmaceutical properties
06/20/2007EP1796632A1 Organo-gel formulations for therapeutic applications
06/20/2007EP1796629A2 Semi-solid delivery vehicle and pharmaceutical compositions
06/20/2007EP1796625A2 Novel fenofibrate formulations and related methods of treatment
06/20/2007EP1796610A2 Transdermal therapeutic system for parkinson's disease
06/20/2007EP1796472A2 Modulation of bio-electrical rhythms via a novel engineering approach
06/20/2007EP1796467A2 Imidazo{4,5-b}pyrazinone inhibitors of protein kinases
1 ... 3705 3706 3707 3708 3709 3710 3711 3712 3713 3714 3715 3716 3717 3718 3719 3720 3721 3722 3723 3724 3725 ... 7860